Audiologists in Ocala, FL Accepting Medicare

26 Audiologists found. Showing 21 - 26

Patricia Michelle Taft, MS Audiologist Medicare: Accepting Medicare Assignments Practice Location: 40 Sw 12th St, Ste 201c, Ocala, FL 34471 Phone: 352-351-3977    Fax: 352-351-8642

Munibah Rahat Ali, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 8620 Sw 103rd Street Rd, Ocala, FL 34481 Phone: 848-200-6643

Dr. Danielle Rosier, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 40 Sw 12th St, Suite C-201, Ocala, FL 34471 Phone: 352-351-3977

Hearing & Balance Solution Audiologist Medicare: Medicare Enrolled Practice Location: 2100 Se 17th St, Suite 202, Ocala, FL 34471 Phone: 352-266-6468

Ms. M. Elizabeth Flechas, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 40 Sw 12th St, Ste 201c, Ocala, FL 34471 Phone: 352-351-3977    Fax: 352-351-8642

Dr. Mark J Kielecki, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3307 Sw 26th Ave, Ocala, FL 34471 Phone: 352-861-3940

News Archive

BioInvent receives FDA IND clearance for BI-204 Phase II trial in cardiovascular disease

BioInvent International AB today announces IND clearance from the U.S. Food & Drug Administration (FDA) to initiate a Phase II study for BI-204. BI-204 is a human monoclonal antibody that specifically targets oxidized forms of a low-density lipoprotein (LDL) which has been linked to increased inflammatory processes leading to plaque formation in the blood vessel walls. BI-204 is being co-developed with Genentech for secondary prevention of cardiovascular events in patients with acute coronary syndrome (ACS).

A.P. Pharma provides update on response to APF530 Complete Response Letter

A.P. Pharma, Inc., a specialty pharmaceutical company, today provided an update on its progress toward responding to the Complete Response Letter for APF530 that the Company received from the U.S. Food and Drug Administration (FDA) in March 2010.

UC Davis researchers develop new intervention to help depressed mothers seek treatment

Researchers at UC Davis have developed a new intervention that identifies potentially depressed mothers and encourages them to seek treatment. The Motivating our Mothers (MOM) program takes a unique approach, relying on pediatricians rather than the mother's doctor for diagnosis.

Study suggests Perfusion CT as noninvasive tool in diagnosis of hepatic toxicity

Liver damage is common in patients with tumor following chemotherapy. Although early liver damage causes no symptoms and is reversible in most patients, it occasionally progresses to more severe liver impairment, which may be irreversible, it is thus necessary to demonstrate the presence and severity of drug-related parenchymal changes.

Read more Medical News

› Verified 8 days ago

• 1
• 2(current)